戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 otency of geldanamycin, but did not affect L-alanosine.
2 and other MTAP-deficient malignancies with L-alanosine.
3       Thus, our results support the use of L-alanosine alone or in combination with a salvage agent a
4 is bound to carbamyl phosphate (CP) and to L-alanosine (an analogue of aspartate).
5                                              Alanosine, an inhibitor of AMP synthesis, inhibited the
6 ells are more sensitive to the toxicity of L-alanosine, an inhibitor of de novo AMP synthesis, than a
7  cells, allows for selective therapy using L-alanosine, an inhibitor of de novo AMP synthesis.
8 trexate, 5,10-dideazatetrahydrofolate, and L-alanosine and by methionine depletion.
9 rve as a predictor of cellular response to L-alanosine and glutathione-mediated resistance to geldana
10 rian SK-OV-3 cells, reduced the potency of L-alanosine and lowered intracellular glutathione levels.
11 e correlations, e.g., amino acid analogue, L-alanosine, and 296 with negative correlations, e.g., gel
12 e that SLC7A11 mediates cellular uptake of L-alanosine but confers resistance to geldanamycin by supp
13                   The therapeutic index of L-alanosine can be increased by the use of a MTAP substrat
14 t strongly supports the kinetic results that alanosine did not inhibit the carbamylation of aspartate
15                                Moreover, the alanosine position in this T-state is somewhat displaced
16 ctive agent for salvaging MTAP+ cells from L-alanosine toxicity and is superior to MTA due to lower c
17 ls obtained at relapse are as sensitive to L-alanosine toxicity as diagnosis samples.
18 electively rescued MTAP+ MOLT-4 cells from L-alanosine toxicity at 25 microM with negligible toxicity
19 TAP+ primary T-ALL cells were rescued from L-alanosine toxicity by the MTAP substrate 5'-deoxyadenosi
20 rinsically MTAP+, would be protected from L.-alanosine toxicity, whereas MTAP-tumor cells would be ki
21 P+ T-ALL cells and normal lymphocytes from L-alanosine toxicity.
22 MTAP(+) cells but not the MTAP(-) cells from alanosine toxicity.
23  MTAP-primary T-ALL cells was inhibited by L-alanosine with a mean IC50 of 4.8+/-5.3 ILM (range, 0.3-

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。